Currently, there are 425.27M common shares owned by the public and among those 268.27M shares have been available to trade.
The company’s stock has a 5-day price change of 46.96% and 53.69% over the past three months. ACHR shares are trading -1.63% year to date (YTD), with the 12-month market performance up to 0.33% higher. It has a 12-month low price of $2.82 and touched a high of $7.01 over the same period. ACHR has an average intraday trading volume of 14.94 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 47.61%, 73.58%, and 53.81% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of Archer Aviation Inc (NYSE: ACHR) shares accounts for 34.46% of the company’s 425.27M shares outstanding.
It has a market capitalization of $2.68B and a beta (3y monthly) value of 2.54. The earnings-per-share (ttm) stands at -$1.33. Price movements for the stock have been influenced by the stock’s volatility, which stands at 12.68% over the week and 9.17% over the month.
Earnings per share for the fiscal year are expected to increase by 27.56%, and 23.36% over the next financial year.
Looking at the support for the ACHR, a number of firms have released research notes about the stock. Needham stated their Buy rating for the stock in a research note on November 19, 2024, with the firm’s price target at $11. H.C. Wainwright coverage for the Archer Aviation Inc (ACHR) stock in a research note released on September 03, 2024 offered a Buy rating with a price target of $12.50. Canaccord Genuity was of a view on June 09, 2023 that the stock is Buy, while Raymond James gave the stock Outperform rating on July 27, 2022, issuing a price target of $8. JP Morgan on their part issued Overweight rating on April 28, 2022.
